Emergency Preparedness and Response
Pillar II: Advance Regulatory Science for MCM Development and Evaluation
What We Do
The Pillar II fosters MCM regulatory science initiatives aimed at helping develop solutions to complex scientific regulatory problems and facilitate the incorporation of new, cutting-edge science into the regulatory review process to make product development more efficient and more predictable.
This program is being implemented through both internal and collaborative research, as well as through partnerships with U.S. government agencies, academia, non-governmental organizations, and industry. An example is MCMi's 2012 Regulatory Science grant to Stanford University for research that will enable the first single-cell comprehensive cross-species analyses of immune system function by mapping the immune responses to certain biothreat agents and possible medical countermeasures.
